Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2016-01-11 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LEVALLOIS-PERRET (92300), Hauts-de-Seine
PHARMACIE JEAN JAURES : revenue, balance sheet and financial ratios
PHARMACIE JEAN JAURES is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LEVALLOIS-PERRET (92300),
this company of category PME
shows in 2022 a revenue of 839 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE JEAN JAURES (SIREN 818136350)
Indicator
2023
2022
2018
2017
Revenue
N/C
839 384 €
790 540 €
1 620 654 €
Net income
-163 372 €
66 976 €
54 497 €
133 507 €
EBITDA
N/C
90 469 €
71 116 €
192 170 €
Net margin
N/C
8.0%
6.9%
8.2%
Revenue and income statement
In 2023, PHARMACIE JEAN JAURES records a net loss of 163 k€. This deficit will reduce equity on the balance sheet.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-163 372 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1190%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 7%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
1190.416%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
6.614%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE JEAN JAURES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2022
2023
Debt ratio
43.341
25.058
0.149
1190.416
Financial autonomy
44.706
66.124
79.323
6.614
Repayment capacity
0.41
0.761
0.007
None
Cash flow / Revenue
8.78%
7.876%
9.08%
None%
Sector positioning
Debt ratio
1190.422023
2018
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Watch+50 pts over 3 years
In 2023, the debt ratio of PHARMACIE JEAN JAURES (1190.42) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
6.61%2023
2018
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average-50 pts over 3 years
In 2023, the financial autonomy of PHARMACIE JEAN JAURES (6.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
0.01 years2022
2018
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Excellent
In 2022, the repayment capacity of PHARMACIE JEAN JAURES (0.01) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 133.41. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
133.414
Liquidity indicators evolution PHARMACIE JEAN JAURES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2022
2023
Liquidity ratio
211.943
429.08
391.164
133.414
Interest coverage
2.646
0.692
0.0
None
Sector positioning
Liquidity ratio
133.412023
2018
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Watch-50 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE JEAN JAURES (133.41) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
0.0x2022
2018
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of PHARMACIE JEAN JAURES (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE JEAN JAURES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2022
2023
Operating WCR
59 105 €
74 714 €
62 895 €
0 €
Inventory turnover (days)
11
26
21
0
Customer payment term (days)
9
6
6
0
Supplier payment term (days)
17
25
43
0
Positioning of PHARMACIE JEAN JAURES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE JEAN JAURES with other companies in the same sector:
Frequently asked questions about PHARMACIE JEAN JAURES
What is the revenue of PHARMACIE JEAN JAURES ?
The revenue of PHARMACIE JEAN JAURES in 2022 is 839 k€.
Is PHARMACIE JEAN JAURES profitable?
PHARMACIE JEAN JAURES recorded a net loss in 2023.
Where is the headquarters of PHARMACIE JEAN JAURES ?
The headquarters of PHARMACIE JEAN JAURES is located in LEVALLOIS-PERRET (92300), in the department Hauts-de-Seine.
Where to find the tax return of PHARMACIE JEAN JAURES ?
The tax return of PHARMACIE JEAN JAURES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE JEAN JAURES operate?
PHARMACIE JEAN JAURES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart